Perspective Therapeutics, Inc., known by its trading symbol CATX on the NYSE American, recently announced a significant change in its stock structure through a

Perspective Therapeutics Announces Reverse Stock Split


blog post cover photo

Image credit: Google Images

  • Perspective Therapeutics, Inc. has announced a 1-for-10 reverse stock split effective June 17, 2024, aiming to consolidate shares and potentially increase stock attractiveness to investors.
  • The reverse stock split follows stockholder approval and is part of the company's strategy to comply with stock market regulations and standards, reflecting ongoing adjustments in its operations.
  • Before the reverse stock split, CATX's stock showed significant volatility, indicative of the challenges in the biotech and pharmaceutical sectors, with a market capitalization of approximately $721.34 million and a trading volume of 8.61 million shares.

Perspective Therapeutics, Inc., known by its trading symbol NYSE:CATX on the NYSE American, recently announced a significant change in its stock structure through a 1-for-10 reverse stock split. This move, effective from June 17, 2024, is a strategic decision aimed at consolidating ten shares of its common stock into one. Perspective Therapeutics operates in the radiopharmaceutical sector, focusing on the development of advanced treatment applications for cancers. This field is highly competitive, with companies constantly striving for innovation in cancer treatment solutions.

The decision for the reverse stock split was made following approval from the company's stockholders at the annual meeting on May 31, 2024. The Board of Directors was authorized to amend the company's certificate of incorporation to facilitate this change. Such a decision is often taken by companies looking to increase their stock price by reducing the number of shares available in the market, potentially making the stock more attractive to investors.

Starting June 17, 2024, CATX's common stock began trading on a split-adjusted basis. Although the trading symbol remained "CATX," the stock was assigned a new CUSIP number, 46489V302. This administrative change reflects the company's ongoing adjustments and its efforts to comply with stock market regulations and standards.

Before the reverse stock split, CATX was trading at $1.07, marking a decrease of 7.76% with a change of -$0.09. The stock experienced fluctuations, ranging between a low of $1.05 and a high of $1.29 on the day of the announcement. Over the past year, the stock has seen significant volatility, with prices ranging from a low of $0.21 to a high of $1.91. This volatility is indicative of the challenges and uncertainties inherent in the biotech and pharmaceutical sectors, especially for companies like Perspective Therapeutics that are focused on developing innovative cancer treatments.

The company's market capitalization, standing at approximately $721.34 million, alongside a trading volume of 8.61 million shares, underscores the scale of its operations and investor interest in its stock. The reverse stock split is a strategic move that could influence the company's stock performance and investor perceptions moving forward.

Other Blogs

Nov 25, 2023 6:39 AM - Parth Sanghvi

DCF Valuation vs. Comparable Companies Analysis: Choosing the Right Valuation Method

Choosing the Right Valuation Method: DCF vs. Comparable Companies Analysis Introduction: Valuation methods play a pivotal role in determining the fair value of a company, aiding investors in making informed investment decisions. Two commonly used methods, DCF Valuation and Comparable Companies A...

blog post title

Dec 23, 2023 2:19 AM - Parth Sanghvi

Understanding the Limitations of DCF Analysis: A Guide to Overcoming Challenges

Introduction: Discounted Cash Flow (DCF) analysis stands as a cornerstone in valuing investments, yet its efficacy is contingent upon various assumptions and methodologies. While a powerful tool, DCF analysis comes with inherent limitations and challenges that investors must acknowledge to make i...

blog post title

Dec 25, 2023 2:28 AM - Parth Sanghvi

Integrating Sustainability into Valuations: Navigating ESG Factors within the Discounted Cash Flow (DCF) Model

Introduction: The investment landscape is undergoing a profound shift with a heightened emphasis on sustainability and responsible investing. In this blog post, we explore the intersection of Environmental, Social, and Governance (ESG) considerations within the Discounted Cash Flow (DCF) model, h...

blog post title


Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
2017-2024 © Financial Modeling Prep